Acupuncture for Primary Insomnia
Acupuncture Treatment of Primary Insomnia
1 other identifier
interventional
60
1 country
1
Brief Summary
This is a randomized controlled trial to evaluate acupuncture treatment on insomnia in the adult population in Hong Kong.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2006
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
February 6, 2009
CompletedFirst Posted
Study publicly available on registry
February 9, 2009
CompletedJanuary 14, 2010
January 1, 2010
9 months
February 6, 2009
January 12, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Self-rated sleep quality score measured by Insomnia Severity Index questionnaire
Baseline, weekly during the treatment course, 1-week posttreatment
Secondary Outcomes (6)
Sleep parameters (sleep onset latency, sleep efficiency, total sleep time, times of wakening during sleep) by objective measure - wrist actigraphy
Baseline, and 1-week posttreatment
Sleep parameters (sleep onset latency, sleep efficiency, total sleep time, times of wakening during sleep) by subjective measures using sleep log.
Baseline, weekly during the treatment course, and 1-week posttreatment
Self-rated sleep quality score measured by the Pittsburgh Sleep Quality Index (PSQI) questionnaire
Baseline, and 1-week posttreatment
Anxiety and depression states measured by Hospital Anxiety and Depression Scale (HADS)
Baseline, and 1-week posttreatment
Subjects' functioning regarding work/study, social life and family measured by Sheehan Disability Index
Baseline, and 1-week posttreatment
- +1 more secondary outcomes
Study Arms (2)
Electroacupuncture
EXPERIMENTALAcupoints will be treated at bilateral Ear Shenmen, Sishencong (EX-HN1), Anmian, and unilateral Yintang (EX-HN3) and Baihui (GV20). Acupuncture will be performed by a registered Chinese medicine practitioner. "De qi"(an irradiating feeling considered to be indicative of effective needling) is achieved if possible. An electric-stimulator (CEFAR Acus II, Lund, Sweden) will be connected to these needles to give an electric-stimulation in continuous wave, frequency of 4 Hz, 0.45 ms square wave pulses and constant current. The needles will be left for 30 min and then removed. Acupuncture treatment will consist of three sessions per week for 3 consecutive weeks.
Placebo Acupuncture
PLACEBO COMPARATORPlacebo needles designed by Streitberger (1998) will be used. The placebo needles are blunt needle that will not penetrate the skin during needle insertion. The handles of these placebo needles will slide over the needle when it is compressed, giving it the appearance of penetrating the skin. The placebo needles are inserted to the same acupoints as stated in the electroacupuncture group. The needles are held by a surgical tape or hair pin in hairy region to imitate the retention of needles. The needles are connected to an electric-stimulator with zero frequency and amplitude. The number, duration and frequency of the treatment sessions, and the intervention procedure will be the same for electro-acupuncture and placebo acupuncture.
Interventions
Acupuncture at bilateral Ear Shenmen, Sishencong EX-HN1, Anmian, and unilateral Yintang EX-HN3 and Baihui GV20. The needles will be left for 30 min and then removed. Acupuncture treatment will consist of three sessions per week for 3 consecutive weeks.
Eligibility Criteria
You may qualify if:
- Hong Kong residents
- aged 18-65
- Ethnic Chinese
- Meet the diagnosis criteria of primary insomnia for at least 3 months according to DSM-IV using the Structured Clinical Interview for DSM-IV (SCID)
- Willing to give informed consent
- total score of Insomnia Severity Index (ISI) at least 15
- Able to comply with trial protocol
You may not qualify if:
- Participation in any clinical trial during the previous 3 months prior to baseline
- Any current major depressive disorder, generalized anxiety disorders or panic disorder, manic or hypomanic episode, substance use disorders besides caffeine and nicotine, organic mental disorder, schizophrenia or any other psychotic disorder as defined by DSM-IV criteria
- Serious physical illness or mental disorders due to a general medical condition which is judged by the investigator to render unsafe
- Valvular heart defects, bleeding disorders or taking anticoagulant drugs.
- Any acupuncture treatment during the previous 12 months prior to baseline.
- In the investigator's opinion, the patient has a significant risk of suicide
- Pregnant, breast-feeding, or woman of childbearing potential not using adequate contraception
- Herbal remedies, over-the-counter medications or psychotropic drugs, which are intended for insomnia, were taken within the last 2 weeks prior to baseline or during the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The University of Hong Konglead
- Hong Kong Baptist Universitycollaborator
- Hong Kong Professional Teachers' Unioncollaborator
Study Sites (1)
Queen Mary Hospital
Hong Kong, Hong Kong
Related Publications (2)
Yeung WF, Chung KF, Yu YB, Lao L. What predicts a positive response to acupuncture? A secondary analysis of three randomised controlled trials of insomnia. Acupunct Med. 2017 Mar;35(1):24-29. doi: 10.1136/acupmed-2016-011058. Epub 2016 Aug 8.
PMID: 27503746DERIVEDYeung WF, Chung KF, Zhang SP, Yap TG, Law AC. Electroacupuncture for primary insomnia: a randomized controlled trial. Sleep. 2009 Aug;32(8):1039-47. doi: 10.1093/sleep/32.8.1039.
PMID: 19725255DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ka-Fai Chung, MBBS
The University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 6, 2009
First Posted
February 9, 2009
Study Start
July 1, 2006
Primary Completion
April 1, 2007
Study Completion
April 1, 2007
Last Updated
January 14, 2010
Record last verified: 2010-01